FAMHP - Federal Agency for Medicines and Health Products
Benedicte Nuyttens is currently working as a Scientific File Manager at the famhp - federal agency for medicines and health products since June 2016. Prior to this, Benedicte held the position of Beleidsmedewerker Cel Drugs at FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu from July 2015 to May 2016. Benedicte also worked as a Scientist at Anacura for a few months in 2015. Benedicte completed their Master in Biomedical Sciences with a minor in research, management, and communication at KU Leuven in 2009, and went on to pursue their PHD at KU Leuven Kulak, focusing on unraveling the platelet-specific role of DCBLD2 until September 2014.
FAMHP - Federal Agency for Medicines and Health Products
The Federal Agency for Medicines and Health Products (FAMHP) is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood products of human origin, human tissue material), for human and veterinary use, in clinical development and on the market. The famhp works together with the academic world, the pharmaceutical industry and the other industries concerned, healthcare professionals, other national, European and worldwide authorities, as well as policy makers, in order to provide everybody with the necessary medicines and health products and to help patients and citizens to use them correctly. The famhp has grown since its creation from an organization with a few dozen employees to an agency that has more than 500 employees which are mostly scientifically trained. The agency consists out of five entities: three Directorates-General, DG PRE authorisation, DG POST authorisation and DG INSPECTION, the support services and the CEO Services.